Vaginitis: Naturopath for Vaginal Infections

Vaginitis: Natural Treatment in Toronto

Last medically reviewed by Dr. Pamela Frank, BSc(Hons), ND – June 28, 2026

Vaginitis (inflammation of the vagina) is one of the most common reasons women seek medical care, accounting for over 10 million clinical visits annually in North America.¹ Its causes are distinct, its treatments are cause-specific, and the most important clinical step is accurate diagnosis. Treating presumed yeast when the actual cause is bacterial vaginosis (or vice versa) does not just fail; it can worsen the condition.

Types of Vaginitis

1. Vulvovaginal Candidiasis (VVC) = Yeast Infection

Yeast infection is the most commonly presumed cause of vaginal symptoms, though not always the actual cause. Approximately 75% of women will have at least one episode of VVC in their lifetime, and 5-8% will develop recurrent VVC (RVVC, defined as ≥4 confirmed episodes per year).² Caused predominantly by Candida albicans (90%), with increasing prevalence of non-albicans species (C. glabrata, C. tropicalis) that may be resistant to standard azole antifungals.

Symptoms of Candida-Driven Vaginitis:

Vulvar pruritus (itching), thick white (“cottage cheese”) discharge without odour or with a yeasty smell, external dysuria (pain or difficulty urinating), vulvar erythema (redness) and swelling.

See the dedicated Yeast Infection page for detailed naturopathic treatment protocols.

2. Bacterial Vaginosis (BV)

BV is characterized by a shift in the vaginal microbiome from Lactobacillus dominance to a polymicrobial overgrowth of anaerobes, including Gardnerella vaginalis, Prevotella spp., Mobiluncus spp., and others, often with formation of a polymicrobial biofilm on the vaginal epithelium.³ This biofilm is a major contributor to BV recurrence. Biofilms protect pathogens from antibiotic penetration and contribute to high recurrence rates (50–70% within 3 months of antibiotic treatment).⁴

Symptoms of BV Vaginitis:

Thin grey-white discharge with a characteristic fishy odour, particularly after intercourse. Itching and burning are less prominent than in VVC. Many cases are asymptomatic.

See the dedicated Bacterial Vaginosis page for detailed treatment protocols.

3. Trichomoniasis

Caused by the flagellated protozoan Trichomonas vaginalis, this is a sexually transmitted infection requiring conventional antibiotic treatment (metronidazole or tinidazole). Naturopathic care in this context focuses on immune support and microbiome restoration post-treatment. If trichomoniasis is suspected, medical diagnosis via a vaginal swab with your MD, and treatment take priority.

4. Atrophic Vaginitis/Genitourinary Syndrome of Menopause (GSM)

In peri- and post-menopausal women, declining estrogen causes thinning and dryness of vaginal tissue (atrophy), loss of vaginal rugae, and pH elevation from loss of Lactobacillus-driven lactic acid production. Symptoms include dryness, dyspareunia (pain with intercourse), burning, spotting, and urinary urgency or recurrent UTIs. This is not an infection but a tissue change that can make one prone to UTIs. See the Menopause & Perimenopause page and Vaginal Dryness page for management options.

5. Aerobic Vaginitis (AV)

This is a distinct entity, often confused with BV, characterized by overgrowth of aerobic organisms (E. coli, Group B Streptococcus, Staphylococcus aureus) and concurrent depletion of vaginal lactobacilli. Presents with yellow-green discharge, vulvar burning, and elevated vaginal pH. Requires culture-guided management with your medical doctor.

6. Contact/Irritant Vaginitis

Chemical or mechanical irritants, such as scented products, douching, spermicides, synthetic fabrics, and latex, can cause vulvovaginal inflammation without any microbial cause. Identification and removal of the irritant is curative.

The Vaginal Microbiome: Why It Matters

The healthy vagina is dominated by Lactobacillus species (particularly L. crispatus, L. iners, L. jensenii, L. gasseri). These maintain a low vaginal pH (3.8–4.5) through lactic acid production, produce hydrogen peroxide and bacteriocins that inhibit pathogen growth, and modulate local immune responses.⁵

Disruption of this Lactobacillus dominance, from antibiotics, sexual activity, altered immune status, hormonal changes, or chronic stress, creates a permissive environment for both bacterial and fungal overgrowth. Supporting the vaginal microbiome is therefore a central strategy in preventing recurrent vaginitis.

Natural Treatment Approach for Vaginitis

Accurate Diagnosis First

Self-diagnosis of vaginal infections is unreliable. Studies show that only 35% of women who self-diagnose yeast infections are correct.⁶ Proper diagnosis requires clinical examination and, for BV, Amsel criteria or Nugent score on microscopy. I work from confirmed diagnoses through your medical doctor.

Probiotic Therapy: Vaginal Microbiome Restoration

Oral probiotic supplementation with evidence-supported Lactobacillus strains is the most validated naturopathic intervention for reducing recurrent vaginitis of both BV and yeast origin:

• L. rhamnosus GR-1 and L. reuteri RC-14: The most studied oral probiotic combination for vaginal health, with RCT evidence for reducing BV recurrence rates and maintaining healthy vaginal microbiome composition.⁷
• Restoration of vaginal Lactobacillus colonization after antibiotic treatment for BV is a key target to reduce recurrence.

Dietary Interventions

• Reduce refined sugars and refined carbohydrates: Elevated glucose availability in vaginal secretions promotes Candida and dysbiotic bacterial growth
• Anti-inflammatory dietary pattern: Supports both immune competence and microbiome diversity
• Probiotic-rich foods: Unsweetened kefir, yogurt with live cultures, fermented vegetables support broader microbiome health

Boric Acid Intravaginally

For recurrent Candida glabrata (a non-albicans species resistant to azoles) and persistent BV, intravaginal boric acid (600-mg capsules) has a well-established evidence base. A 2011 review in the Journal of Women’s Health found boric acid achieved clinical cure rates of 70–80% in azole-resistant candidiasis.⁸ This is within the prescribing scope of naturopathic doctors in Ontario. Boric acid is toxic if taken orally and must only be used vaginally as specifically directed.

Immune Support

Recurrent vaginal infections frequently reflect an underlying immune deficit. Relevant investigations include: vitamin D status (VDR-mediated immune function at mucosal surfaces), zinc (key for innate immune response), iron studies (iron deficiency is immunosuppressive), and glucose/insulin status (hyperglycemia impairs neutrophil function).

Hormonal Assessment

For perimenopausal and postmenopausal women with atrophic-pattern vaginitis, endocrine system support through vitamins, minerals, and appropriate botanicals can strengthen vaginal tissue.

Lab Testing for Recurrent Vaginitis

These tests can all inform management of recurrent cases of vaginitis.

Self-assessment: Vaginal pH measurement

Through your MD (OHIP-covered) or through a Naturopath in Toronto (not OHIP covered): Full hormone panel (particularly in perimenopausal women), thyroid panel, CBC, vitamin D, glucose/insulin

Vaginal microbiome DNA testing (where available – Naturopathic Doctors in Ontario cannot order vaginal microbiome testing)

Through your MD: microscopy (wet prep), Nugent score, vaginal culture with sensitivity (for azole-resistant Candida or aerobic organisms), and STI screen.

Frequently Asked Questions About Vaginitis

What is the most common cause of vaginitis?

Bacterial vaginosis (BV) is the most common cause of vaginal symptoms in women of reproductive age, accounting for approximately 40–50% of vaginitis cases. Vulvovaginal candidiasis (yeast) accounts for approximately 20–25%, and trichomoniasis accounts for approximately 15–20%. The remainder includes aerobic vaginitis, atrophic vaginitis, and contact/irritant vaginitis. Because treatment differs completely between these causes, accurate diagnosis before treatment is essential. Self-treating presumed yeast with an over-the-counter antifungal when the actual cause is BV is one of the most common reasons vaginal symptoms persist or worsen.

Can vaginitis go away on its own?

It depends entirely on the cause. Mild contact or irritant vaginitis often resolves once the trigger is removed. Some functional yeast infections in women with a robust vaginal microbiome may self-resolve, though this is less reliable. BV rarely resolves spontaneously and tends to recur even after treatment. The polymicrobial biofilm that characterizes BV is self-sustaining and typically requires active intervention. Trichomoniasis does not resolve without antibiotic treatment. Atrophic vaginitis in menopause is a tissue change driven by estrogen deficiency and can improve with post-menopause endocrine system support. When in doubt, symptoms warrant clinical assessment rather than watchful waiting, particularly because untreated BV carries risks beyond discomfort, including increased susceptibility to STIs and, in pregnancy, preterm birth.

Is vaginitis an STI?

Not necessarily. BV and yeast vaginitis are not classified as sexually transmitted infections, though sexual activity, including new or multiple partners, and both male and female partners, can alter the vaginal microbiome and trigger or recur BV. Trichomoniasis is an STI caused by a flagellated protozoan (Trichomonas vaginalis) and requires partner testing and treatment. Atrophic vaginitis, contact vaginitis, and aerobic vaginitis are not sexually transmitted. However, because some STIs (chlamydia, gonorrhea, herpes) can produce vaginal discharge or irritation that resembles vaginitis, STI screening is appropriate in the workup of vaginal symptoms when clinically indicated.

Why does vaginitis keep coming back?

Recurrence is the central clinical problem in vaginitis, particularly BV and yeast infections. The key reasons:

For BV: the Gardnerella vaginalis-led polymicrobial biofilm on the vaginal epithelium is highly antibiotic-resistant. Antibiotics (metronidazole, clindamycin) reach the bacteria in the vaginal fluid but penetrate the biofilm poorly, meaning the reservoir of organisms embedded in the biofilm survives treatment and repopulates the vagina within weeks. Recurrence rates of 50–70% within 3 months of standard antibiotic treatment reflect this mechanism. Without restoring Lactobacillus dominance after treatment, the ecological niche previously occupied by BV organisms remains open.

For yeast: recurrent vulvovaginal candidiasis (≥4 confirmed episodes per year) is often driven by non-albicans Candida species resistant to standard azole antifungals (particularly C. glabrata), by immune factors (vitamin D deficiency, blood sugar dysregulation reducing neutrophil function), by disrupted vaginal microbiome ecology, or by antibiotic use repeatedly wiping out protective lactobacilli. In some women, the partner harbours Candida on penile skin and causes reinfection, though this is not universal.

Can a yeast infection cause BV or vice versa?

BV and yeast can coexist simultaneously, causing mixed vaginitis, though they are caused by distinct organisms and mechanisms. BV involves anaerobic bacterial overgrowth with loss of lactobacilli; yeast involves Candida fungal overgrowth. Antibiotic treatment for BV (metronidazole, clindamycin) disrupts the remaining vaginal lactobacilli and creates conditions favourable to Candida overgrowth, which is why yeast infections commonly follow antibiotic treatment for BV. The reverse, yeast triggering BV, is less mechanistically direct, but both reflect the same underlying state: disrupted Lactobacillus dominance. Microbiome restoration after any antibiotic course is therefore important regardless of which condition prompted treatment.

Does diet affect vaginitis?

Yes, meaningfully. High intake of refined sugar and refined carbohydrates elevates glucose in vaginal secretions, directly promoting Candida growth. Candida requires glucose as a primary carbon source for proliferation and biofilm formation. In women with poorly controlled blood sugar or insulin resistance, recurrent yeast vaginitis is a predictable consequence. A low-glycemic-index dietary pattern reduces this substrate availability. For BV, the connection is less direct but operates through systemic immune function and microbiome diversity; diets high in processed foods and low in dietary fibre reduce short-chain fatty acid production, which supports immune regulation. Probiotic-rich fermented foods (unsweetened kefir, live-culture yogurt, kimchi, sauerkraut) support gut microbiome diversity, which in turn influences the vaginal microbiome through systemic immune modulation.

Can stress cause vaginitis?

Chronic psychological stress does not directly cause vaginal infections, but it creates conditions that increase susceptibility. HPA axis activation from chronic stress elevates cortisol, which suppresses both innate and adaptive immune function, including the mucosal immune defences in the urogenital tract that keep Candida and dysbiotic bacteria from overgrowing. Cortisol also elevates blood glucose through gluconeogenesis, further feeding Candida. Additionally, stress dysregulates the gut microbiome through cortisol’s effects on gut motility and intestinal permeability, with downstream effects on vaginal microbiome composition. Women who notice vaginitis flares during high-stress periods are not imagining the connection; the biological pathway is real.

Can vaginitis affect fertility?

BV in particular has well-documented reproductive consequences. In pregnancy, BV is associated with a two-fold increased risk of preterm birth, preterm premature rupture of membranes, and late miscarriage. Outside of pregnancy, BV increases susceptibility to upper genital tract infections (pelvic inflammatory disease) by disrupting the cervical mucus barrier and allowing ascending bacterial migration. PID is a leading cause of tubal factor infertility and ectopic pregnancy. In women undergoing IVF, BV at the time of embryo transfer is associated with reduced implantation rates. Trichomoniasis is similarly associated with adverse reproductive outcomes. For women who are trying to conceive, screening for and treating BV and other vaginal infections is an important component of preconception care.

What is the vaginal pH and why does it matter?

The healthy vagina maintains an acidic pH of approximately 3.8–4.5, primarily due to lactic acid produced by Lactobacillus species. This acidity is a key defence mechanism: it directly inhibits the growth of most uropathogens and BV-associated anaerobes, which require a higher pH to establish and sustain overgrowth. BV is reliably associated with vaginal pH >4.5; pH measurement is one of the four Amsel criteria used to diagnose BV clinically. Candida species are more pH-tolerant and can grow at normal acidic pH, which is why yeast infections are not reliably detected by pH alone. Vaginal pH strips are available over-the-counter and can be a useful initial self-triage tool, though pH alone does not replace clinical diagnosis.

What is aerobic vaginitis, and how is it different from BV?

Aerobic vaginitis (AV) is a distinct entity that is frequently misdiagnosed as BV. Both involve loss of Lactobacillus dominance and elevated vaginal pH, but the overgrowth in AV involves aerobic organisms, most commonly Escherichia coli, Group B Streptococcus (Streptococcus agalactiae), and Staphylococcus aureus, rather than the anaerobic polymicrobial community of BV. AV typically presents with yellow, purulent discharge, significant vulvovaginal burning, and sometimes mucosal erosions. It does not respond to metronidazole (an anaerobic antibiotic) and requires culture-guided treatment targeting the specific aerobic organism identified. If your vaginal symptoms have not responded to multiple courses of BV antibiotics, aerobic vaginitis is worth considering and requires proper vaginal culture with sensitivity testing to identify.

What is the difference between vaginitis and vaginosis?

“Vaginitis” literally means inflammation of the vagina and encompasses any condition causing vaginal inflammation, including yeast, BV, trichomoniasis, atrophic changes, aerobic infection, and contact irritation. “Vaginosis” specifically refers to bacterial vaginosis; the “osis” suffix denotes a dysbiotic state (overgrowth without primary inflammation) rather than classical infection with tissue inflammation. BV was renamed from “bacterial vaginitis” to “bacterial vaginosis” in the 1980s to reflect that the BV vaginal environment, while dysbiotic, does not consistently show the neutrophil infiltration characteristic of true inflammation, unlike aerobic vaginitis, which does. In clinical practice, the terms are sometimes used interchangeably, which is imprecise but common.

Can I use hydrogen peroxide for BV?

Intravaginal hydrogen peroxide (H₂O₂) has been studied as a treatment for BV. Lactobacillus crispatus naturally produces hydrogen peroxide in the vagina, which contributes to its inhibition of BV-associated organisms. A small number of studies have explored exogenous intravaginal H₂O₂ as an alternative to antibiotics, with mixed results. A 2003 Italian RCT found H₂O₂ douching was as effective as metronidazole for BV in a small sample, but methodological limitations and the broader evidence base for douching, which consistently shows harm to the vaginal microbiome, make routine H₂O₂ douching inadvisable. Boric acid has considerably stronger evidence base and is the preferred alternative for antibiotic-resistant or recurrent cases.

Any intravaginal self-treatment should be discussed with a healthcare provider before use, particularly if you may be pregnant.

Should my partner be treated if I have vaginitis?

It depends on the type. For trichomoniasis, yes, always. Trichomoniasis is sexually transmitted; partners must be simultaneously treated to prevent ping-pong reinfection, and abstinence or condom use is required until both partners complete treatment. For BV, the evidence on partner treatment is nuanced. Male partners: multiple RCTs of simultaneous male partner antibiotic treatment have not consistently reduced BV recurrence in heterosexual women, so this is not the current standard practice. However, condom use consistently reduces BV recurrence rates in sexually active women, suggesting semen (which is alkaline and disrupts vaginal pH) and penile microbiome play a role.

Female partners of women with BV: there is robust evidence that BV is transmitted between female sexual partners, concordance rates in female same-sex couples are high, and partner treatment is more clinically relevant in this context. For yeast: partner treatment is not routinely recommended unless the partner is symptomatic, though some evidence suggests penile Candida carriage may contribute to recurrence in some couples.

Can vaginitis be caused by hormonal birth control?

Hormonal contraceptives can influence vaginal microbiome ecology, though the relationship is complex and varies by contraceptive type. Combined oral contraceptives maintain relatively stable estrogen levels, which generally support vaginal epithelial cell glycogen production and Lactobacillus colonization. Progestin-only methods, particularly depot medroxyprogesterone acetate (Depo-Provera), can reduce estrogen levels, thinning vaginal epithelium and potentially disrupting Lactobacillus dominance.

Levonorgestrel IUDs have minimal systemic hormonal effects, but the intrauterine device itself can theoretically serve as a surface for biofilm formation in BV-susceptible women. Copper IUDs have no hormonal effects but are associated in some studies with increased BV prevalence, possibly through effects on the local immune environment and cervical mucus. If vaginal infections appeared or worsened after starting a hormonal contraceptive, this timeline is clinically relevant information worth discussing.

The Benefits of Naturopathic Treatment of Vaginitis

1. Naturopathic treatment addresses the underlying cause of recurring bacterial vaginosis (BV), recurring yeast infections, or other causes of vaginitis to resolve the condition on a long-term basis.
2. Better overall health and hormone balance
3. A stronger, healthier immune system

by Dr. Pamela Frank, BSc(Hons), ND

---

References for Natural Treatment of Vaginitis

1. Sobel JD. Vaginitis. N Engl J Med. 1997 Dec 25;337(26):1896-903. doi: 10.1056/NEJM199712253372607. PMID: 9407158.
2. Foxman B, Marsh JV, Gillespie B, Sobel JD. Frequency and response to vaginal symptoms among white and African American women: results of a random digit dialing survey. J Womens Health. 1998 Nov;7(9):1167-74. doi: 10.1089/jwh.1998.7.1167. PMID: 9861594.
3. Swidsinski A, Mendling W, Loening-Baucke V, Swidsinski S, Dörffel Y, Scholze J, Lochs H, Verstraelen H. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol. 2008 Jan;198(1):97.e1-6. doi: 10.1016/j.ajog.2007.06.039. Epub 2007 Nov 19. PMID: 18005928.
4. Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, Moss LM, Horvath LB, Kuzevska I, Fairley CK. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis. 2006 Jun 1;193(11):1478-86. doi: 10.1086/503780. Epub 2006 Apr 26. PMID: 16652274.
5. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, Forney LJ. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1(Suppl 1):4680-7. doi: 10.1073/pnas.1002611107. Epub 2010 Jun 3. PMID: 20534435; PMCID: PMC3063603.
6. Ferris DG, Nyirjesy P, Sobel JD, Soper D, Pavletic A, Litaker MS. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol. 2002 Mar;99(3):419-25. doi: 10.1016/s0029-7844(01)01759-8. PMID: 11864668.
7. Reid G, Bocking A. The potential for probiotics to prevent bacterial vaginosis and preterm labour. Am J Obstet Gynecol. 2003 Oct;189(4):1202-8. doi: 10.1067/s0002-9378(03)00495-2. PMID: 14586379.
8. Iavazzo C, Gkegkes ID, Zarkada IM, Falagas ME. Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence. J Womens Health (Larchmt). 2011 Aug;20(8):1245-55. doi: 10.1089/jwh.2010.2708. Epub 2011 Jul 20. PMID: 21774671.

For help with vaginitis, BV, yeast infections or any other health problem, book an appointment here or call the office for more information at 416-481-0222.

Dr. Pamela Frank has been in practice as a naturopathic doctor for over 26 years. Since 1999, she has earned acclaim as a leading naturopath in Toronto, amassing multiple awards.

Dr. Pamela has a special interest in addressing hormone-related complexities, including but not limited to PCOS, endometriosis, acne, hair loss, weight management, thyroid issues, and fertility.

Residing in Toronto with her family and loyal companion, Dolly the rescue dog, Dr. Pamela seamlessly combines her professional commitment with a diverse range of interests.

Beyond her clinical endeavours, she actively engages in kickboxing, leadership roles within Scout Groups, yoga practice, podcasting, and outdoor pursuits such as backcountry camping.

Dr. Pamela’s comprehensive approach reflects not only her dedication to optimal health but also her passion for continual personal and professional growth.